Skip to main content

MOORE CAPITAL MANAGEMENT, LP

Position in RGEN — Repligen Corp

CIK 1448574 NEW YORK, NY

Position in RGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,123,185
-$19,455,815 QoQ
Shares Held
37,549
-75.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#128
of 476 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RGEN Over Time

Shares Held

Position Value (USD)

Derivatives in RGEN

reported options exposure · as of Sep 30, 2025
CallValue
$1,069,360
CallShares
8,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $33,433,894 across 9 Medical Instruments & Supplies names. RGEN ranks #3 (15.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 RGEN
Repligen Corp
This page
37,549 $5,123,185

All Filings in RGEN

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,123,185 37,549
2025-12-31 $24,579,000 150,000
2025-09-30 $1,069,360 8,000
2025-09-30 $19,382,150 145,000
2024-06-30 $6,303,000 50,000
2023-12-31 $6,293,000 35,000
2023-09-30 $3,975,250 25,000